Market Closed -
Other stock markets
|
After market 14:46:26 | |||
19.36 EUR | +1.10% | 19.3 | -0.34% |
04-19 | Jefferies raises target for Evonik to €20 - 'Hold' | DP |
04-19 | EVONIK : Jefferies reaffirms its Neutral rating | ZD |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.8 for the current period. Therefore, the company is undervalued.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company is one of the best yield companies with high dividend expectations.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company does not generate enough profits, which is an alarming weak point.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.68% | 9.53B | A | ||
+11.61% | 63.22B | A- | ||
-3.51% | 46.34B | A- | ||
+13.09% | 39.97B | B+ | ||
+17.83% | 25.46B | A- | ||
+8.37% | 18.68B | C+ | ||
+0.88% | 17.24B | B+ | ||
-20.33% | 15.81B | A- | ||
+0.36% | 14.9B | B+ | ||
-13.44% | 13.74B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- EVK Stock
- Ratings Evonik Industries AG